Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year […]
Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective […]
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) to a sell rating in a research report released on Wednesday. Other analysts also recently issued research reports about the company. Piper Sandler reduced their price objective on Codexis from $14.00 to $10.00 and set an overweight rating for the company in a research report on […]
Trellus Management Company LLC decreased its position in shares of Codexis, Inc. (NASDAQ:CDXS – Free Report) by 12.5% during the third quarter, HoldingsChannel reports. The firm owned 220,000 shares of the biotechnology company’s stock after selling 31,460 shares during the period. Trellus Management Company LLC’s holdings in Codexis were worth $416,000 at the end of […]